Please provide your email address to receive an email when new articles are posted on . There has been quite an evolution of IOLs since their inception. In the era of refractive cataract surgery, ...
Please provide your email address to receive an email when new articles are posted on . The challenges associated with accommodating IOLs are well known and include variable efficacy, reliance upon ...
Dec. 12, 2003 — Editor's Note: On Nov. 14, Eyeonics, Inc., received U.S. Food and Drug Administration (FDA) approval to market the first accommodating intraocular lens (Crystalens) that allows ...
LensGen, a California-based developer of intraocular lenses (IOL) for the treatment of presbyopia and cataracts, has announced the release of $11 million in Series A funding. The funds are part of the ...
The annual symposium of the American Society of Cataract & Refractive Surgery (ASCRS) took place in Washington, DC, from April 15-20, 2005. The meeting's paper sessions highlighted the increasing ...
SAN FRANCISCO--For most people, the need to wear eyeglasses to read is an inevitable part of aging. The eye's natural lens hardens and loses its ability to change shape, making it more difficult to ...
Intraocular lenses (IOLs), implanted in the eye as treatment for cataracts or myopia, are a growing global market in an ageing population, one estimated to be worth more than $4.5 billion by 2022.
Bausch + Lomb has announced it is extending the rebate program for patients who have the company’s Crystalens accommodating intraocular lens implanted before March 31, 2011. Patients will be eligible ...
Bausch & Lomb has introduced Crystalens AO, an aberration free accommodating intraocular lens with aspheric optics, according to a Bausch & Lomb news release. The Crystalens AO has prolate aspheric ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results